Código QR (código de barras bidimensional)

P60 | TRIAL IN PROGRESS, MoMMent-3: A PROSPECTIVE, MULTINATIONAL, REAL-WORLD STUDY OF TALQUETAMAB IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

Background. The prospective, non-interventional, multinational LocoMMotion (NCT04035226) and MoMMent (NCT05160584) studies demonstrated poor outcomes and no well-established real-world standard-of-care treatments in patients with triple-class exposed RRMM beginning treatment in 2019-2022 (Weisel et...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Principais autores: K. Weisel, E. Kastritis, E. Gonzalez-Garcia, S. Gentili, C. Renner, P. Ferraz, N. Francella, S. Sitar, J. Buyze, N. Healy, N.M. Suñé, P. Moreau, M.V. Mateos
Format: Artigo
Sprog:Inglês
Udgivet: Ferrata Storti Foundation 2026-04-01
Serier:Haematologica
Online adgang:https://haematologica.org/article/view/14056
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!